Maccura Biotechnology Co Ltd (300463) — Capital Reinvestment Ratio

Latest as of September 2025: 1.19x

Maccura Biotechnology Co Ltd (300463) has a Capital Reinvestment Ratio of 1.19x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥148.82 Million) in capital expenditures (CN¥176.79 Million). See Maccura Biotechnology Co Ltd (300463) free cash flow to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

1.19x
Capex / Operating Cash Flow

Operating Cash Flow

CN¥148.82 Million
CNY

Capital Expenditures

CN¥176.79 Million
CNY

Data as of

Sep 2025
Most recent filing

Maccura Biotechnology Co Ltd Capital Reinvestment Ratio (2011–2025)

This chart tracks Maccura Biotechnology Co Ltd's Capital Reinvestment Ratio across 15 annual periods.

Annual Capital Reinvestment Ratio for Maccura Biotechnology Co Ltd (2011–2025)

Year-by-year Capital Reinvestment Ratio for Maccura Biotechnology Co Ltd from 2011 to 2025. For live market cap and broader valuation context, see Maccura Biotechnology Co Ltd market cap and net worth.

Year Reinvestment Ratio Operating CF (CNY) Capital Expenditures YoY Change
2025 1.24x CN¥602.33 Million CN¥749.07 Million ▼ -18.2%
2024 1.52x CN¥633.80 Million CN¥963.02 Million ▲ +57.9%
2023 0.96x CN¥912.09 Million CN¥877.90 Million ▼ -17.8%
2022 1.17x CN¥843.22 Million CN¥987.74 Million ▲ +214.7%
2021 0.37x CN¥1.62 Billion CN¥601.78 Million ▼ -18.8%
2020 0.46x CN¥1.09 Billion CN¥501.32 Million ▼ -58.3%
2019 1.10x CN¥459.52 Million CN¥504.67 Million ▼ -59.8%
2018 2.73x CN¥193.91 Million CN¥529.95 Million ▼ -53.3%
2017 5.85x CN¥79.03 Million CN¥462.36 Million ▼ -25.8%
2016 7.88x CN¥49.32 Million CN¥388.75 Million ▲ +18.2%
2015 6.67x CN¥33.18 Million CN¥221.31 Million ▲ +376.5%
2014 1.40x CN¥115.09 Million CN¥161.10 Million ▲ +28.0%
2013 1.09x CN¥98.39 Million CN¥107.56 Million ▲ +75.7%
2012 0.62x CN¥110.96 Million CN¥69.03 Million ▼ -35.9%
2011 0.97x CN¥85.55 Million CN¥82.99 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow